Avience Biomedicals Ltd

NSE: AVIENCE · Healthcare · 6 announcements

Share price: ₹342.05
Market cap: ₹187.6 Cr
Revenue (annual): ₹52.51 Cr
Net profit (annual): ₹8.75 Cr
P/E (TTM): 21.4×Sector 57.8×
Promoter holding: 64.59%
FII holding: 3.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Annual General Meeting 2 Other Announcement 1 Financial Results 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

28 Jul 2026 23:38 IST NSE

Earnings Call

Avience Biomedicals Earnings Call Transcript: Key Takeaways

Avience Biomedicals reported FY26 revenue of ₹52.51 Cr (up 16%) with EBITDA margins improving to 28.45%. Strategy focuses on shifting from trading to in-house manufacturing and scaling exports.

Call: Guides 60% growth

Open call summary → Read the filing ↗

24 Jul 2026 13:25 IST NSE

Earnings Call

Avience Biomedicals Investor Presentation: Key Takeaways

Avience Biomedicals Limited reports 16% FY26 revenue growth with EBITDA margins expanding to 28.45%. Strategy focuses on capacity expansion via a new ₹30.18 Cr automated facility and increasing CDSCO product approvals.

Call: Guides 60% growth

Open call summary → Read the filing ↗